Menthol cigarette smoking-related blood metabolites and lung cancer risk
薄荷醇香烟与吸烟相关的血液代谢物和肺癌风险
基本信息
- 批准号:10653537
- 负责人:
- 金额:$ 9.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-01 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdenocarcinomaAffectAfrican AmericanAfrican American populationAgeAmericanBiologicalBiological AssayBloodBlood specimenCancer EtiologyCarcinogensCessation of lifeCharacteristicsCigaretteCohort StudiesCommunitiesCotinineDataDiagnosisDiagnosticDisparityDisparity populationDrug Metabolic DetoxicationElasticityEpidemiologyEthnic OriginEthnic PopulationEtiologyEuropeanFundingFutureGoalsInterdisciplinary StudyInvestigationKnowledgeLinear ModelsLinkLiver MicrosomesLogistic RegressionsLow incomeMalignant NeoplasmsMalignant neoplasm of lungMentholMetabolicMetabolismModificationMolecularMovementNested Case-Control StudyNicotinePathogenicityPathway AnalysisPathway interactionsPlasmaPopulation StudyProspective StudiesProspective cohortPublic HealthQuestionnairesRaceRandom AllocationReportingResearchRiskRisk FactorsRoleSmokerSmokingSocioeconomic StatusStandardizationStatistical ModelsTobaccoValidationVariantWomancancer health disparitycancer riskcigarette smokingcost efficientepidemiologic dataepidemiology studyethnic disparityhazardinnovationinsightlung cancer preventionlung carcinogenesismalemenmetabolic profilemetabolomicsnicotine exposurenovelpopulation basedpreventable deathracial disparityracial populationsexsmoking-related disease
项目摘要
SUMMARY
African Americans (AAs) bear a disproportionately high burden of lung cancer (LC)―AA males have a much
higher likelihood of developing LC and dying from LC than any other race and ethnic groups. Currently, little is
known about the potential contributors to the LC disparities. Menthol cigarette smoking is the most distinctive
feature that defines AA smokers, leading to speculation that menthol cigarette smoking may contribute, in part,
to the extra burden of LC among AAs. However, epidemiologic studies to date could not bring a full explanation
of the role and/or harms of menthol cigarette smoking in LC etiology owing to questionnaire-only investigations,
potential reverse causality, and insufficient numbers of AAs, menthol smokers, and examined metabolites.
Moreover, previous studies did not comprehensively explore the underlying mechanisms of menthol cigarette
smoking and lung carcinogenesis, highlighting the need for innovative research to investigate the hidden clues
that can explain disproportional burdens and disparities related to menthol cigarette smoking among AAs. To
fill the knowledge gaps in epidemiologic evidence and address the actual hazards of menthol cigarettes in LC
etiology, we propose the first population-based prospective study incorporating a multi-stage metabolomics
approach to identify the menthol cigarette smoking-related metabolites and their associations with LC risk in a
comprehensive and cost-efficient way. Leveraging pre-diagnostic blood samples, rich epidemiologic data, and
recently generated metabolomics data in the Southern Community Cohort Study (SCCS), an NCI-funded
prospective cohort, we aim to 1) identify menthol cigarette smoking-related blood metabolites using the
Metabolon’s Global Metabolomics platform (~1,500 metabolites in eight super pathways) among 959 cancer-
free current smokers (617 AAs and 342 EAs) and further evaluate the possible associations of menthol
cigarette smoking-related blood metabolites with race, sex, age, smoking intensity/duration, and other
known/suggested risk factors for LC (Aim 1); and 2) conduct a nested case-control study to investigate the
associations of each menthol cigarette smoking-related metabolite and a standardized metabolite risk score
with LC risk, using pre-diagnostic blood samples of 80 pairs of incident LC cases (adenocarcinoma) and
matched controls who were selected from cancer-free AA male current smokers within the SCCS (Aim 2).
Findings from this proposed study will advance our knowledge of the actual hazards of menthol cigarette
smoking in LC etiology, provide important insight into the pathogenic/molecular pathways of menthol cigarette
smoking, and generate valuable information to develop new public health strategies for LC prevention mainly
targeted at racially/ethnically disadvantaged people. Furthermore, this proposed study will bring a mechanistic
explanation of menthol cigarette smoking, a potential contributor to a disproportionately high burden of LC
among AAs, and thus help elucidate hidden clues underlying the racial/ethnic disparities in LC, which fills the
knowledge gaps in LC disparities research regarding the smoking paradox among AAs.
总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
QIUYIN CAI其他文献
QIUYIN CAI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('QIUYIN CAI', 18)}}的其他基金
Searching the blood metabolome to identify risk biomarkers for biliary tract cancer
搜索血液代谢组以确定胆道癌的风险生物标志物
- 批准号:
10614032 - 财政年份:2022
- 资助金额:
$ 9.86万 - 项目类别:
Searching the blood metabolome to identify risk biomarkers for biliary tract cancer
搜索血液代谢组以确定胆道癌的风险生物标志物
- 批准号:
10453004 - 财政年份:2022
- 资助金额:
$ 9.86万 - 项目类别:
Individual and social contextual factors in relation to DNA methylation, biological aging, and lung cancer risk
与 DNA 甲基化、生物衰老和肺癌风险相关的个人和社会背景因素
- 批准号:
10474423 - 财政年份:2021
- 资助金额:
$ 9.86万 - 项目类别:
Identification of Genes and DNA Methylation Markers for Lung Cancer Risk by Integrating Multi-omics Data
通过整合多组学数据鉴定肺癌风险基因和 DNA 甲基化标记
- 批准号:
10331874 - 财政年份:2021
- 资助金额:
$ 9.86万 - 项目类别:
Identification of Genes and DNA Methylation Markers for Lung Cancer Risk by Integrating Multi-omics Data
通过整合多组学数据鉴定肺癌风险基因和 DNA 甲基化标记
- 批准号:
10531620 - 财政年份:2021
- 资助金额:
$ 9.86万 - 项目类别:
Individual and social contextual factors in relation to DNA methylation, biological aging, and lung cancer risk
与 DNA 甲基化、生物衰老和肺癌风险相关的个人和社会背景因素
- 批准号:
10306010 - 财政年份:2021
- 资助金额:
$ 9.86万 - 项目类别:
Individual and social contextual factors in relation to DNA methylation, biological aging, and lung cancer risk
与 DNA 甲基化、生物衰老和肺癌风险相关的个人和社会背景因素
- 批准号:
10600037 - 财政年份:2021
- 资助金额:
$ 9.86万 - 项目类别:
Exome Sequencing to identify Novel Genetic Factors for Lung Cancer in Nonsmokers
外显子组测序鉴定非吸烟者肺癌的新遗传因素
- 批准号:
9248773 - 财政年份:2012
- 资助金额:
$ 9.86万 - 项目类别:
相似国自然基金
大肠癌发生机制的adenoma-adenocarcinoma pathway同serrated pathway的关系的研究
- 批准号:30840003
- 批准年份:2008
- 资助金额:12.0 万元
- 项目类别:专项基金项目
相似海外基金
Synergistic Radiosensitization of Hypoxic Pancreatic Adenocarcinoma using Gd-Texaphyrin Oxygen-Loaded Nanodroplets
使用 Gd-Texaphyrin 载氧纳米液滴对缺氧胰腺腺癌进行协同放射增敏
- 批准号:
478914 - 财政年份:2023
- 资助金额:
$ 9.86万 - 项目类别:
Operating Grants
Expression mechanism of immune checkpoint molecules after carbon-ion radiotherapy in cervical adenocarcinoma specimens
宫颈腺癌碳离子放疗后免疫检查点分子的表达机制
- 批准号:
23K14913 - 财政年份:2023
- 资助金额:
$ 9.86万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Study of fibrosis in pancreatic ductal adenocarcinoma (PDAC) and application of adipose-derived stromal/stem cells for PDAC treatment
胰腺导管腺癌(PDAC)纤维化的研究以及脂肪源性基质/干细胞在 PDAC 治疗中的应用
- 批准号:
23K15035 - 财政年份:2023
- 资助金额:
$ 9.86万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Therapeutic Targeting of NSD2 in Lung Adenocarcinoma
NSD2 在肺腺癌中的治疗靶向
- 批准号:
10657069 - 财政年份:2023
- 资助金额:
$ 9.86万 - 项目类别:
IRAK4 AS A NOVEL IMMUNOTHERAPEUTIC TARGET IN PANCREATIC DUCTAL ADENOCARCINOMA
IRAK4 作为胰腺导管腺癌的新型免疫治疗靶点
- 批准号:
10442874 - 财政年份:2023
- 资助金额:
$ 9.86万 - 项目类别:
Molecular mechanisms for development of pulmonary invasive mucinous adenocarcinoma
肺浸润性粘液腺癌发生的分子机制
- 批准号:
23H02698 - 财政年份:2023
- 资助金额:
$ 9.86万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Control mechanisms of lung adenocarcinoma by SGLT2 inhibitors for treating diabetes mellitus.
SGLT2抑制剂治疗糖尿病对肺腺癌的控制机制。
- 批准号:
23K08326 - 财政年份:2023
- 资助金额:
$ 9.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of histological transformation model from lung small cell carcinoma from adenocarcinoma to explore the therapeutic strategies of small cell lung carcinoma.
建立肺小细胞癌腺癌组织学转化模型,探讨小细胞肺癌的治疗策略。
- 批准号:
23K14614 - 财政年份:2023
- 资助金额:
$ 9.86万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms of tumor progression controlled by tumor-initiating cells and cancer-associated fibroblasts in pancreatic adenocarcinoma.
阐明胰腺腺癌中肿瘤起始细胞和癌症相关成纤维细胞控制的肿瘤进展机制。
- 批准号:
23K15075 - 财政年份:2023
- 资助金额:
$ 9.86万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidating the Cellular Origins of lung adenocarcinoma
阐明肺腺癌的细胞起源
- 批准号:
10743611 - 财政年份:2023
- 资助金额:
$ 9.86万 - 项目类别:














{{item.name}}会员




